Rheumatology
Conference Coverage
EULAR’s COVID-19 recommendations offer no surprises
The provisional recommendations cover four themes: general measures and preventing SARS-CoV-2 infection, managing patients without COVID-19 and...
Conference Coverage
Age leads COVID-19 hospitalization risk factors in RMDs
Glucocorticoid use, cardiovascular comorbidity, and male gender were also found to increase the risk of hospitalization from COVID-19 in...
Conference Coverage
Most rheumatology drugs don’t increase COVID-19 hospitalization risk
“These results provide, for the first time, information about the outcome of COVID-19 in patients with rheumatic and musculoskeletal diseases.”
Conference Coverage
COVID-19 vaccine won’t be a slam dunk
A key safety concern to watch for in the coming months is whether a vaccine candidate is able to sidestep the issue of antibody-dependent...
Conference Coverage
TNF inhibitors may dampen COVID-19 severity
New findings from the COVID-19 Global Rheumatology Alliance Registry.
News
ACR gives guidance on rheumatic disease management during pandemic
When COVID-19 is suspected, rheumatic disease patients may continue their hydroxychloroquine but other rheumatic disease treatments may need to be...
Conference Coverage
Biologics better solo than with methotrexate in psoriatic arthritis
Ustekinumab or a tumor necrosis factor inhibitor are better used alone than with methotrexate in the treatment of psoriatic arthritis.
News
Case series suggests biologics, JAK inhibitors safe during pandemic
Investigators saw no increase in hospitalizations versus the general population in New York City.
News
Price increases for RA biologics keep out-of-pocket costs high for Medicare patients
Yearly increases in the price of rheumatoid arthritis biologics have largely negated initial savings in out-of-pocket costs tied to the Affordable...
News
COVID-19: Frequently asked clinical questions
Should I continue to vaccinate my pediatric population during peak COVID-19?